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Abstract
Background: Asthma mortality has declined since the 1980s. Nevertheless the World Health Organization (WHO)
identified asthma as responsible for 225.000 deaths worldwide in 2005, and 430.000 fatal cases are expected by 2030.
Some unexpected and concentrated fatal asthma events all occurred between 2013 and 2015 in Veneto, a North
Eastern region of Italy, which prompted a more in-depth investigation of characteristics and risk factors.
Methods: A web search including key words related to fatal asthma in Italy between 2013 and 2015 has been
performed. Concerning the cases that occurred in Veneto, subjects’ clinical records have been evaluated and details
about concomitant weather conditions, pollutants and pollen count have been collected.
Results: Twenty-three cases of asthma deaths were found in Italy; 16 of them (69%) occurred in the Veneto Region.
A prevalence of male and young age was observed. Most of patients were atopic, died in the night-time hours and
during the weekends. The possible risk factors identified were the sensitization to alternaria, previous near fatal asthma
attacks and the incorrect treatment of the disease. Weather condition did not appear to be related to the fatal
exacerbations, whereas among the pollutants only ozone was detected over the accepted limits. Smoking habits,
possible drug abuse and concomitant complementary therapies might be regarded as further risk factors.
Discussion: Although not free from potential biases, our web search and further investigations highlight an
increasing asthma mortality trend, similarly to what other observatories report. The analysis of available clinical
data suggests that the lack of treatment more than a severe asthma phenotype characterizes the fatal events.
Conclusions: Asthma mortality still represents a critical issue in the management of the disease, particularly in
youngsters. Once more the inadequate treatment and the lack of adherence seem to be not only related to the
uncontrolled asthma but also to asthma mortality.
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Background
Asthma mortality declined since the 1980s, at least in
Europe and in the United States [1–4]. The widespread
use of inhaled steroids probably accounts for it [5].
Nevertheless the World Health Organization (WHO)
identified fatal asthma as responsible for 225.000 deaths
worldwide in 2005 and, according to the current trend,
for 430.000 by 2030 [6, 7]. Also in Italy, a reduction in
asthma deaths was registered in the period 2009–12 [8],
and most of recorded cases were elderly (>60 years)
(Fig. 1). The prevalence of fatal asthma in older age might
be related to the inaccuracy of certification procedures. In
fact, several studies have proved an overestimation of
asthma mortality in the elderly, with a degree of inaccur-
acy in certification ranging from 39 to 80% [9, 10]. The in-
correct identification of Chronic Obstructive Pulmonary
Disease (COPD) instead of asthma as the cause of death
appears to be responsible for many wrong certifications.
In fact the terms “asthma” and “COPD” have come to
be used interchangeably, because both conditions share
the airflow obstruction as well as similar medications
[11]. Furthermore the presence and severity of comor-
bidities might hamper the identification of the main
cause of death in elderly asthmatics patients. On the
contrary near-fatal or fatal asthma seems to be partly
restricted to youngsters or adults below 50 years and
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under the epidemiological perspective, they can be con-
sidered as part of the same disease cluster [12, 13]. In a
recent study evaluating a large series of patients af-
fected by near-fatal asthma (NFA), the majority of them
were youngsters or adults below 50 years [14]. However,
despite its relevance in terms of epidemiology and emo-
tional impact, fatal asthma is not yet fully understood and
preventable. In fact on a clinical ground it shows a very
heterogeneous phenotype, characterized by variable causes
and risk factors. Thus asthma mortality still represents a
critical issue in the management of the disease.
Three unexpected cases of fatal asthma occurred in
Padua (a town in the North East of Italy) in July 2015.
This was the starting point for a more extensive evalu-
ation of fatal asthma in our region. We aimed at analyz-
ing asthma deaths that occurred in the last 3 years
(2012–2015) in the Veneto region, in the North East of
Italy, in order to identify and highlight characteristics
and risk factors of fatal asthma.
Methods
Acknowledging the intrinsic flaws of the official data
produced by ISTAT, the Italian National Institute of Sta-
tistics [8], the identification of cases and circumstances
of asthma deaths was carried out in three different steps.
a. In order to detect recent cases of fatal asthma in
Italy a web search was performed using Google™.
The following key words were included:
[fatal asthma], [asthma death], [asthma mortality].
The time frame ranged from 2013 to 2015. In fact, a
longer interval might negatively affect the availability
and reliability of clinical data.
b. Concerning the cases occurring in Veneto Region,
a more in-depth investigation was carried out.
i. The full newspaper articles were collected. Data
about circumstances of death, such as date and
place, as well as age and gender of cases were
extrapolated.
ii. Subjects’ clinical records were searched at the
Emergency Departments of the Hospitals where
the patients had been admitted or among the
medical files of their GPs.
iii. Information concerning the weather conditions
(temperature, humidity, rainfall, thunderstorm),
the levels of pollutants (O3, PM10, NO2) and the
pollen count at the time and at the place of the
fatal attack were collected from the website of the
regional Agency for the Environment Prevention
and Protection (ARPA), www.arpa.veneto.it [15].
Results
Twenty-four cases of asthma deaths were found in Italy
within the indicated time frame (2013–2015); 17 of them
(71%) occurred in the Veneto Region.
Demographic data are shown in Table 1. Three out of 17
subjects were female (17.6%) and the mean age was
26.1 years (range 11–51). However most of the patients
were under 41 years old: 35% were between 10 and 20 years
old, 53% between 21 and 40 years old and the other ones
were older. According to the region of origin, most of
patients were Italian (71%) whereas four subjects were im-
migrants, coming respectively from Russia, Romania,
Morocco and Philippines. Seven patients were students;
among the adults three of them were unemployed.
Overall, patients died at home (59%) and only three
patients reached the Emergency Room. Three cases died
during outdoor activities. Ten patients had the fatal at-
tacks during the weekend (59%) and the decease oc-
curred in the evening or during nighttime. The temporal
distribution of the deaths over the year showed a cluster
between June and October, when nine patients died.
Seven patients died between November and March.
Considering the weather condition at the place and
time of the fatal attacks, the temperature was in line
with the seasonal average values, rainfalls generally were
absent and no thunderstorms were registered (Table 2).
Regarding airborne pollutants, in four cases an in-
crease of PM10 (one case, AB) and O3 (three cases, ST,
MA and OZ) significantly over the accepted values was
registered in concomitance with the fatal attacks (Fig. 2).
Figure 3 shows the pollen count data at the time and
place of the events. An Alternaria peak was registered in
six cases (AR, SH, MP, AV, MA, OZ) and a medium con-
centration was detected in concomitance with three other
fatal attacks (RB, ST, RT). A 3 days long lasting Parietaria
increase was reported in three cases (ST, AR, MP).
Complete clinical details were obtained for eight pa-
tients, partial details for five, whereas in the remaining
four cases the diagnosis was confirmed by the autopsy
but the preexisting clinical data were lacking (Table 3).
Fig. 1 Trend of asthma mortality according to the Italian National
Institute of Statistics (ISTAT) from 2009 to 2012
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According to the available clinical data, all the patients
were atopic. Grass pollens, mite and Alternaria were the
most common sensitizers. None of the patients was on
regular treatment, but according to the medical files, 13
patients were advised to take short acting beta agonist
(SABA) as needed and irregularly courses of inhaled
corticosteroids (ICS) alone or in combination with long
acting beta agonists. Smoking habit, food allergy, drug
abuse, physical exercise, concomitant use of comple-
mentary therapies were reported as potential risk factors
in several cases. Three patients were repeatedly admitted
to ER before the fatal attack and were treated with
Table 2 Weather conditions at the place and time of fatal attacks
Patient’s initials Place (County) Date Time Temperature (°C) Rainfall Thunderstorm Place of death Day of the week
GP Padua 01.11.13 1 AM 11° Absent Absent Outdoor FRI
JV Padua 07.01.14 8 PM 5° Absent Absent At home WED
LM Treviso 27.02.14 3 AM 8° Absent Absent Hospital THU
SM Venice 14.03.14 10 PM 10° Absent Absent Hospital FRI
RB Verona 16.06.14 5 PM 16° Absent Absent Hospital MON
ST Padua 08.08.14 8 PM 24° Absent Absent At home FRI
AR Verona 30.08.14 2 AM 22° Absent Absent At home SAT
SH Padua 13.09.14 10 PM 19° 1 mm Absent At home SAT
MP Padua 29.09.14 8.30 PM 17° Absent Absent Outdoor MON
AV Vicenza 17.10.14 11.30 PM 18° Absent Absent At home FRI
KS Treviso 12.11.14 4 AM 12° Absent Absent At home WED
EA Padua 19.12.14 7 AM 6° Absent Absent At home FRI
KK Venice 01.03.15 7 PM 9° Absent Absent Train station SUN
RT Padua 11.07.15 11 PM 23° Absent Absent At home SAT
MA Padua 18.07.15 9 PM 29° Absent Absent At home FRI
OZ Padua 19.07.15 3 AM 26° Absent Absent Outdoor SAT
AB Padua 05.11.15 3 AM 12° Absent Absent At home WED
Table 1 Demographic data of patients and place and time of fatal events
Patient’s initials Place (county) Age Gender Nationality Time of death Occupation Place of death Day of the week
GP Padua 18 M Italy 1 AM student Outdoor FRI
JV Padua 16 M Italy 8 PM student At home WED
LM Treviso 22 M Italy 3 AM mechanic Hospital THU
SM Venice 22 M Italy 10 PM chef Hospital FRI
RB Verona 10 M Italy 5 PM student Hospital MON
ST Padua 15 M Italy 8 PM student At home FRI
AR Verona 34 M Italy 2 AM employee At home SAT
SH Padua 26 M Morocco 10 PM unemployeed At home SAT
MP Padua 33 F Italy 8.30 PM painter Outdoor MON
AV Vicenza 11 M Italy 11.30 PM student At home FRI
KS Treviso 21 M Romania 4 AM employee At home WED
EA Padua 42 F Philippines 7 AM unemployeed At home FRI
KK Venice 54 M Russia 7 PM employee Train station SUN
RT Padua 18 M Italy 11 PM student At home SAT
MA Padua 30 M Italy 9 PM student At home FRI
OZ Padua 41 M Morocco 3 AM unemployeed Outdoor SAT
AB Padua 31 F Italy 3 AM journalist At home WED
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epinephrine and oxygen supplies. In 14 cases the autopsy
confirmed the diagnosis. In one subject (MP), besides
the massive lymphocytic and eosinophilic inflammatory
infiltrate occluding the bronchial lumen, alternaria was
detected in the airways together with mucus plugs
(Fig. 4). In two cases the autopsy was not performed, ac-
cording to the certainty of the clinical diagnosis.
Discussion
Seventeen cases of fatal asthma, all occurring in the
same Italian region within the last 3 years, have been de-
tected and analyzed. A prevalence of male gender, young
age and atopic condition was observed. Several risk
factors have been identified such as sensitization to Alter-
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Fig. 2 Levels of pollutants (NO, PM10 and O3) registered at the place and at the time of the deaths. On x-axis patients’ initials are reported.
In 3 days the concentration of ozone was above the accepted limits (120 μcg/m3), whereas only in 1 day the level of PM10 was significantly
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Fig. 3 Aerobiological data at the time and places of the deaths are shown. On x-axis patients’ initials are reported. The pollen count was low for
all pollens detected (grass, birch, parietaria and ragweed) whereas in 6 days a high concentration of alternaria was registered
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treatment of the disease. Weather condition or thunder-
storms did not trigger the fatal exacerbation, whereas
among the pollutants only ozone was detected over the
accepted limits during the days when the deaths occurred.
We observed an increased asthma rate in young males,
much younger then in ISTAT asthma deaths database
[8], compared to young females [16]. It may be related
to the prevalence of male gender among the described
cases. However, the prevalence of male gender reflects
what is known in the general population [8]. Most of
subjects (44%) were students whereas three adult pa-
tients were unemployed. The last were all immigrants,
suggesting difficult access to the health care resources as
a potential risk factor for uncontrolled asthma. In fact,
one patient had been admitted to the Emergency Room
several hours before his death, but voluntarily he went
away from the waiting room. Four hours later he was
found dead in a street nearby, with the inhaler in his
hand. The other two cases had the fatal attack at home,
but they had not been visited by a doctor during the last
years. The autopsy proved the causal role of asthma in
all these fatal cases. This finding is in agreement with
the higher mortality noticed in populations with lower
income, such as black or Hispanic in the United States.
However, differently from economical issues, racial
factors at least in youngsters seemed not to affect
asthma severity [17]. Of note, according to a large USA
study that investigated the outcomes of patients hospi-
talized for asthma, race was not relevant as a risk factor
for hospital deaths. Caucasian patients show an overall
lower risk of death in comparison with black patients,
but factors preceding hospitalization, such as lower in-
come, do probably account for it [18].
The cluster of fatal attacks during the weekend em-
phasizes the potential role of smoking, drug or alcohol
abuse, which are quite common during parties or other
entertainment among youngsters, as negative cofactors
in determining the decease. Smoking habit is still
Table 3 Clinical features of patients suffering from fatal asthma
Patient’s
initials
Atopy Follow-up Concomitant risk
factors
Allergic sensitizations Asthma treatment History of Hospital/ER admissions
GP Present infrequent Smoking, party, physical
exercise
NR Intermittent use fo SABA any
JV Present NR Physical exercise NR Intermittent use fo SABA Any
LM Present Infrequent Heavy smoker Grass, mites, peach Intermittent use fo SABA In childhood 3 years in an high altitude
hospital, recently several admission to
ER for asthma exacerbations
SM Present Infrequent Smoking Mites SABA as needed Admission to ER for asthma exacerbation;
treated with epinephrine and Oxigen
supply




Mites, Parietaria, grass Intermittent use of SABA
and short courses of ICS
Any
ST Present regular Severe asthma in
childhood
Mites, grass, alternaria SABA as needed. Short
courses of ICS
Any
AR Present infrequent Dinner Grass, mites alternaria Intermittent use of ICS-LABA
and SABA as needed
Any
SH NR NR NR NR NR NR
MP Present infrequent NR Grass, Alternaria ICS-LABA, short courses of
oral steroids
Any





Intermittent use of ICS
Any
KS NR NR NR NR NR NR
EA NR NR NR NR NR NR
KK NR NR NR NR° NR NR
RT Present 2 Food allergy Grass, parietaria,
mites
SABA as needed, short
courses of ICS
Any
MA present 2 NR Mites, Alternaria° SABA as needed Any
OZ present 4 Drug abuse, heavy
smoker
Referred mites SABA as needed Many admissions to ER
AB present Infrequent NR Mites SABA as needed Any
NR not reported
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common in young people. All the studies including ado-
lescents reported higher rates of smoking in asthmatics
than in non-asthmatic peers, though this trend is less
consistent in adults [19]. Moreover, an increased pre-
valence of asthma and COPD has been reported in pa-
tients who smoke crack or cocaine [20].
In our series, most of the fatal cases occurred in the
evening and during the night. It is well known that noc-
turnal exacerbations occur in 2/3 of asthmatics, contrib-
uting to the morbidity and mortality of the disease [21].
Several factors might account for this finding, such as
changes in respiratory function related to sleep as well
as processes related to circadian regulation. Further-
more, concomitant diseases, such as gastro-esophageal
reflux or sleep apnea may negatively affect the airway re-
sistance overnight [21].
Weather conditions seemed not to be related to fatal at-
tacks, as temperatures were in line with the average values
of the season and there was no rainfall or thunderstorm in
the critical days (Table 2). Only ozone was over the per-
mitted threshold for 3 days. It has been shown that this
pollutant is responsible for airway inflammation, as it in-
creases the pro-inflammatory markers and oxidative stress
in bronchial epithelial cells [22]. This finding was mainly
observed in atopic individuals, in children as well as in
adults [22, 23]. In our series one of the fatal events oc-
curred in concomitance with a high level of ozone. He
was atopic and a heavy smoker and it is possible that the
pollution might have played a negative role by increasing
airways inflammation.
Regarding the aerobiological data, the high concentra-
tion of Alternaria spores, with an overall low pollen
count, also suggests a relevant role of this allergenic
source [12]. The sensitization to this fungal mould was
confirmed in five patients and maybe related to the fatal
events. Moreover in one patient, besides the massive
lymphocytic and eosinophilic inflammation in the bron-
chial airways, Alternaria was detected in the airways
Fig. 4 A massive infiltration and airways obstruction has been detected in the airways of a patient who died during the summer (a). The image
shows a section of bronchus - hematoxylin-eosin stain - magnification × 100. Red arrow: bronchial lumen occluded by amorphous eosinophilic
material corresponding to mucus plugs, mixed with inflammatory cells and epithelial cells. Green arrow: peribronchial and sub-mucosal hyperaemia,
thickening of the basal membrane with muscle hypertrophy. Blue arrow: neutrophilic and limphomonocitary inflammation. The patient was sensitized
to alternaria, which was detected in the airways (b); the outdoor concentration of the fungal mold was high at the time of the death
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(Fig. 4). As previously described [24], the inflammatory
reaction triggered by an allergen is responsible for a
massive production of mucus and a decrease of the airway
clearance function. Once the mucus plugging becomes ex-
tensive, even a slight bronchial muscle constriction on top
of the plugs can cause the complete airway occlusion.
Since 1991 Alternaria has been reported as responsible
for NFA and fatal asthma [25], and epidemic asthma in
the late summer and autumn was repeatedly reported with
a peak of multiple hospital admissions in young asth-
matics [26–28]. Several mechanisms may account for
alternaria-induced exacerbations. In fact, besides the IgE
mediated allergic inflammation, an Alternaria-specific
serine protease activity is responsible for an immediate
release of IL-33, which drives a robust Th2 inflamma-
tion and exacerbation of allergic airway disease [29].
Furthermore, the Alternaria induced IL-33 production
can provoke a steroid resistance, as in children sensi-
tized to this fungal mould a relationship between levels
of IL-33 and use of oral steroids has been demonstrated
[30]. In our series most of the patients were atopic, al-
though not in all the cases the sensitization could pos-
sibly account for the death. Nevertheless, several
patients of our series seemed to belong to a cluster of a
recently identified NFA phenotype, whose features are the
younger age, the smoking habit and the sensitization to
Alternaria [14].
Respiratory infections might account for the cases of
fatal asthma registered in winter [31], but this connec-
tion cannot be confirmed according to the clinical files
of our cases.
In our case series, three patients were previously ad-
mitted to Emergency Rooms or Hospitals for near-fatal
asthma (respiratory failure with hypercapnia). These pa-
tients, who can be classified as severe asthmatics accord-
ing to the European Respiratory Society (ERS)
Guidelines [32], indirectly confirm that severe asthma
exacerbations remain a robust predictive risk factor for
asthma mortality [33–35]. In the other patients the iden-
tification of the level of asthma severity is not easy. In
fact according to the concomitant treatment reported in
medical files, patients were affected by GINA level 2 or
3 [36], but detailed data about the concomitant asthma
control are lacking. According to the UK National Re-
view of Asthma Deaths [35], the largest study worldwide
investigating asthma deaths, only 39% of patients were
affected by severe asthma at the time of death. The other
subjects suffered from mild to moderate asthma. Those
findings suggest that undertreated and poorly controlled
asthma rather than severe asthma is at high risk of fatal
exacerbation.
Among the cases we have investigated, only one pa-
tient was regularly monitored, whereas the remaining
cases were not regularly followed-up by their GPs. The
lack of specialist and general practitioner supervision
during the 12 months prior to death also characterizes
the majority of fatal cases reported in the UK National
Review of Asthma Deaths. As a probable consequence, a
minority of patients was provided with a personal action
plan and 45% of people seemed not to seek medical as-
sistance before death [35].
All the described subjects shared the use of SABA as
needed and only intermittent courses of ICS alone or in
combination with LABA. This finding suggests that all
the patients were using a rescue treatment but they did
not follow a regular anti-inflammatory action plan. More-
over the underuse of ICS in comparison with SABA, con-
firmed by the GPs prescription in seven cases, suggests a
low adherence to the anti-inflammatory treatment. Re-
cently in patients with mild asthma the excessive use of
SABA was identified as a reliable marker of poor control
and increased risk of severe exacerbation [33, 34]. The
over-prescription of SABA and the under-prescription of
preventer medication have been described as a key finding
of the UK National Review of Asthma Deaths [35]. In-
appropriate prescribing of long-acting beta agonists was
also highlighted: 14% of fatal asthma cases were prescribed
a single-component bronchodilator, without any inhaled
corticosteroid preventer treatment. However, the treat-
ment of life-threatening asthma during the acute phase
still represents a challenge. Some authors have suggested
the use of epinephrine intramuscular auto-injector as an
extreme emergency treatment able to save lives [37].
In our case series, for one patient the concomitant use
of complementary medicine was reported. The intake of
herbal or homeopathic remedies has been reported as a
risk factor for uncontrolled asthma, as patients reduce
or stop the pharmacological treatment in favor of the
complementary treatment [38].
One major flaw of this survey is the method used for
searching fatal asthma cases. The prevalence of patients
below 40 years may be due to a “mediatic bias” since
deaths at younger ages are more striking and more easily
reported. Given this limitation, the identification of
causes and risk factors can be more understandable at
younger ages for the lack of relevant concomitant dis-
eases, which are common in elderly and can be a con-
founding factor.
Conclusions
Asthma mortality still represents a critical issue in the
management of the disease. Our case series, prompted
by some unexpected and concentrated fatal asthma
events, lead to a more in-depth investigation of charac-
teristics and risk factors. Surprisingly, a young age of the
fatal asthma cases was found. The association between
Alternaria sensitization and asthma mortality is proved
in our study and suggests that asthmatics allergic to this
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mould have to be carefully monitored during summer
and autumn and regularly treated. In our series, a high
level of ozone in the environment and the smoking habit
could have had a negative impact on the fatal attack. Fi-
nally, once more the inadequate treatment and the lack
of adherence seem to be not only related to the uncon-
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